Company Overview | Monexa AI | Monexa

BAYN.DE Financial Overview

Comprehensive financial analysis and stock performance data for BAYN.DE. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

BAYN.DE

Bayer AG

Healthcare
CEO: William N. Anderson
IPO: 1996-12-16
90,587 employees
EUR27.67
0.63 (2.26%)

Market Cap

27.18B

Enterprise Value

63B

Revenue (TTM)

46.6B

Net Income

-2,552,000,000

P/E Ratio

-8.36x

ROE

-9.96%

Valuation Metrics
Market Cap
27B
Enterprise Value
63B
P/E Ratio
-8.36x
P/S Ratio
0.58x
P/B Ratio
0.84x
EV/Sales
1.34x
EV/FCF
11.86x
Earnings Yield
-11.97%
FCF Yield
19.40%
Price to Operating Cash Flow
3.40x
Gross Margin
53.99%
Margin Metrics
Operating Margin
6.36%
Net Margin
-6.98%
Pretax Margin
-6.64%
ROIC
3.63%
Dividends
Payout Ratio
-3.87%
Dividend Yield
0.40%
Dividend per Share
$0.11
Return Metrics
ROE
-9.96%
ROCE
3.65%
ROA
-2.98%
PEG Ratio
0.30x
Payout Ratio
-3.87%
Financial Health
Debt to Assets
36.07%
Net Debt/EBITDA
4.38x
Growth Metrics
3Y Revenue Growth
1.87%
5Y Revenue Growth
1.35%
10Y Revenue Growth
-0.74%
3Y Net Income Growth
NaN%
5Y Net Income Growth
NaN%
10Y Net Income Growth
NaN%
3Y OCF Growth
13.13%
5Y OCF Growth
-2.15%
10Y OCF Growth
0.66%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

Error loading chart data. Please try refreshing the page.